Bone marrow edema syndrome (BMES), is a rare and self-limiting condition characterized by localized bone pain and transient marrow edema visible on MRI. BMES has been increasingly associated with specific cutaneous manifestations that may hold diagnostic and prognostic significance. Patients with BMES have reported localized erythema, dermal thickening, and induration overlying the affected joints, which are hypothesized to reflect microvascular compromise and inflammatory processes within the bone and adjacent soft tissues. Dermatologic signs are likely linked to regional hyperemia, venous stasis, and cytokine-mediated inflammation, paralleling the pathophysiological mechanisms underlying intraosseous edema. Elevated intraosseous pressure in BMES may disrupt local perfusion, resulting in ischemia-reperfusion injury and subsequent vascular leakage, which manifests in visible cutaneous changes. Pro-inflammatory mediators, such as interleukin-1β and vascular endothelial growth factor (VEGF), central to BMES pathogenesis, may exacerbate endothelial activation, and dermal involvement. Histopathologic studies of affected skin have revealed perivascular lymphocytic infiltration and increased dermal vascularity, further supporting the theory of a shared ischemic and inflammatory pathway between bone and skin. Although MRI remains the gold standard for BMES diagnosis, recognition of these cutaneous manifestations could expedite orthopedic referral and intervention, especially in cases where imaging is delayed or symptoms are ambiguous. Current treatment options, including bisphosphonates, prostacyclin analogs, and offloading of weight bearing, may benefit from integration with dermatologic strategies to alleviate localized cutaneous symptoms and improve patient comfort. Evaluating the molecular and vascular links between BMES and its cutaneous manifestations provides an opportunity to refine diagnostic protocols and therapeutic approaches, offering a comprehensive understanding of the systemic interplay between dermal and skeletal pathophysiology, and optimizing clinical outcomes for patients affected by BMES.
References
[1]
Li, S., Yu, H., Long, S., Li, J., He, Y., Zheng, X., et al. (2023) Research Advances in the Treatment of Bone Marrow Edema Syndrome. Journal of Clinical Densitometry, 26, Article 101367. https://doi.org/10.1016/j.jocd.2023.03.006
[2]
Mirghasemi, S.A., Trepman, E., Sadeghi, M.S., Rahimi, N. and Rashidinia, S. (2016) Bone Marrow Edema Syndrome in the Foot and Ankle. Foot & Ankle International, 37, 1364-1373. https://doi.org/10.1177/1071100716664783
[3]
Korompilias, A.V., Karantanas, A.H., Lykissas, M.G. and Beris, A.E. (2008) Bone Marrow Edema Syndrome. Skeletal Radiology, 38, 425-436. https://doi.org/10.1007/s00256-008-0529-1
[4]
Starr, A.M., Wessely, M.A., Albastaki, U., Pierre-Jerome, C. and Kettner, N.W. (2008) Bone Marrow Edema: Pathophysiology, Differential Diagnosis, and Imaging. Acta Radiologica, 49, 771-786. https://doi.org/10.1080/02841850802161023
[5]
Marchalik, D., Lipsky, A., Petrov, D., Harvell, J.D. and Milgraum, S.S. (2012) Dermatologic Presentations of Orthopedic Pathologies. American Journal of Clinical Dermatology, 13, 293-310. https://doi.org/10.2165/11595880-000000000-00000
[6]
Davis, D.D. and Kane, S.M. (2024) Bone Marrow Edema Syndrome. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK559176/
[7]
Eustace, S., Keogh, C., Blake, M., Ward, R.J., Oder, P.D. and Dimasi, M. (2001) MR Imaging of Bone Oedema: Mechanisms and Interpretation. Clinical Radiology, 56, 4-12. https://doi.org/10.1053/crad.2000.0585
[8]
Plenk, H., Hofmann, S., Eschberger, J., Gstettner, M., Kramer, J., Schneider, W., et al. (1997) Histomorphology and Bone Morphometry of the Bone Marrow Edema Syndrome of the Hip. Clinical Orthopaedics and Related Research, 334, 73-84. https://doi.org/10.1097/00003086-199701000-00010
[9]
Lakhanpal, S., Ginsburg, W.W., Luthra, H.S. and Hunder, G.G. (1987) Transient Regional Osteoporosis. Annals of Internal Medicine, 106, 444-450. https://doi.org/10.7326/0003-4819-106-3-444
[10]
Cahir, J.G. and Toms, A.P. (2008) Regional Migratory Osteoporosis. European Journal of Radiology, 67, 2-10. https://doi.org/10.1016/j.ejrad.2008.01.051
[11]
Hofmann, S. (2005) The Painful Bone Marrow Edema Syndrome of the Hip Joint. Wiener klinischeWochenschrift, 117, 111-120. https://doi.org/10.1007/s00508-005-0322-2
[12]
Aigner, N., Petje, G., Steinboeck, G., Schneider, W., Krasny, C. and Landsiedl, F. (2001) Treatment of Bone-Marrow Oedema of the Talus with the Prostacyclin Analogue Iloprost. The Journal of Bone and Joint Surgery, 83, 855-858. https://doi.org/10.1302/0301-620x.83b6.11377
[13]
Hofmann, S., Kramer, J., Vakil-Adli, A., Aigner, N. and Breitenseher, M. (2004) Painful Bone Marrow Edema of the Knee: Differential Diagnosis and Therapeutic Concepts. Orthopedic Clinics of North America, 35, 321-333. https://doi.org/10.1016/j.ocl.2004.04.005
[14]
Roemer, F.W., Frobell, R., Hunter, D.J., Crema, M.D., Fischer, W., Bohndorf, K., et al. (2009) MRI-Detected Subchondral Bone Marrow Signal Alterations of the Knee Joint: Terminology, Imaging Appearance, Relevance and Radiological Differential Diagnosis. Osteoarthritis and Cartilage, 17, 1115-1131. https://doi.org/10.1016/j.joca.2009.03.012
[15]
Patel, S. (2013) Primary Bone Marrow Oedema Syndromes. Rheumatology, 53, 785-792. https://doi.org/10.1093/rheumatology/ket324
[16]
Unay, K., Poyanli, O., Akan, K., Guven, M. and Demircay, C. (2009) The Relationship between Bone Marrow Edema Size and Knee Pain. Knee Surgery, Sports Traumatology, Arthroscopy, 17, 1298-1304. https://doi.org/10.1007/s00167-009-0842-9
[17]
Radke, S., Vispo-Seara, J., Walther, M., Ettl, V. and Eulert, J. (2001) Transient Bone Marrow Oedema of the Foot. International Orthopaedics, 25, 263-267. https://doi.org/10.1007/s002640100253
[18]
Sprinchorn, A.E., O'Sullivan, R. and Beischer, A.D. (2011) Transient Bone Marrow Edema of the Foot and Ankle and Its Association with Reduced Systemic Bone Mineral Density. Foot & Ankle International, 32, 508-512. https://doi.org/10.3113/fai.2011.0508
[19]
Arazi, M., Yel, M., Uguz, B. and Emlik, D. (2006) Be Aware of Bone Marrow Edema Syndrome in Ankle Arthroscopy: A Case Successfully Treated with Iloprost. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 22, 909.e1-909.e3. https://doi.org/10.1016/j.arthro.2006.05.011
[20]
Akhavan, S., Martinkovich, S.C., Kasik, C. and DeMeo, P.J. (2020) Bone Marrow Edema, Clinical Significance, and Treatment Options: A Review. Journal of the American Academy of Orthopaedic Surgeons, 28, e888-e899. https://doi.org/10.5435/jaaos-d-20-00142
[21]
Dick, A., Schwartzman, G. and Khachemoune, A. (2022) Cutaneous Manifestations of Sickle Cell Disease: An Updated Review. Archives of Dermatological Research, 315, 729-734. https://doi.org/10.1007/s00403-022-02466-5
[22]
Cao, J., Zhang, C., Huang, H., Yang, L. and Duan, X. (2021) Bone Marrow Edema Syndrome of the Foot Treated with Extracorporeal Shock Wave Therapy: A Retrospective Case Series. The Journal of Foot and Ankle Surgery, 60, 523-528. https://doi.org/10.1053/j.jfas.2020.10.007
[23]
Buck, M. and Delaney, M. (2014) Diagnosis and Management of Gout in Total Knee Arthroplasty. Orthopaedic Nursing, 33, 37-40. https://doi.org/10.1097/nor.0000000000000021
[24]
Manara, M. and Varenna, M. (2014) A Clinical Overview of Bone Marrow Edema. Reumatismo, 66, 184-196. https://doi.org/10.4081/reumatismo.2014.790
[25]
Littman, J., Gil, H. and Aaron, R. (2023) Spontaneous Bone Marrow Edema: Perfusion Abnormalities and Treatment with Surgical Decompression. International Journal of Molecular Sciences, 24, Article 6761. https://doi.org/10.3390/ijms24076761
[26]
Richarz, N.A., Boada, A. and Carrascosa, J.M. (2017) Angiogenesis in Dermatology—Insights of Molecular Mechanisms and Latest Developments. Actas Dermo-Sifiliográficas, 108, 515-523. https://doi.org/10.1016/j.ad.2016.12.001
[27]
Wang, F., Luo, A., Xuan, W., Qi, L., Wu, Q., Gan, K., et al. (2019) The Bone Marrow Edema Links to an Osteoclastic Environment and Precedes Synovitis during the Development of Collagen Induced Arthritis. Frontiers in Immunology, 10, Article 884. https://doi.org/10.3389/fimmu.2019.00884
[28]
Sabat, R., Wolk, K., Loyal, L., Döcke, W. and Ghoreschi, K. (2019) T Cell Pathology in Skin Inflammation. Seminars in Immunopathology, 41, 359-377. https://doi.org/10.1007/s00281-019-00742-7
[29]
Choi, J.E. and Di Nardo, A. (2018) Skin Neurogenic Inflammation. Seminars in Immunopathology, 40, 249-259. https://doi.org/10.1007/s00281-018-0675-z
[30]
De Berardinis, L., Qordja, F., Farinelli, L., Faragalli, A., Gesuita, R. and Gigante, A.P. (2022) Is Primary Bone Marrow Edema of the Knee Associated with Thyroid Disorders? A Retrospective Clinical Study. Journal of Clinical Medicine, 11, Article 5973. https://doi.org/10.3390/jcm11195973
[31]
Fujita, S., Morikawa, T., Tamaki, S., Sezaki, M., Takizawa, H., Okamoto, S., et al. (2022) Quantitative Analysis of Sympathetic and Nociceptive Innervation across Bone Marrow Regions in Mice. Experimental Hematology, 112, 44-59.e6. https://doi.org/10.1016/j.exphem.2022.07.297
[32]
Habuchi, H., Izumi, M., Dan, J., Ushida, T., Ikeuchi, M., Takeuchi, K., et al. (2021) Bone Marrow Derived Mast Cells Injected into the Osteoarthritic Knee Joints of Mice Induced by Sodium Monoiodoacetate Enhanced Spontaneous Pain through Activation of PAR2 and Action of Extracellular ATP. PLOS ONE, 16, e0252590. https://doi.org/10.1371/journal.pone.0252590
[33]
King, H.L., Benedetti, G.B., Keller, J.J., DeLoughery, T.G., Shatzel, J.J. and Martens, K.L. (2024) Dermatologic Manifestations of Hematologic Disorders. Annals of Hematology, 103, 3889-3903. https://doi.org/10.1007/s00277-024-05761-5
[34]
Patel, L.M., Lambert, P.J., Gagna, C.E., Maghari, A. and Lambert, W.C. (2011) Cutaneous Signs of Systemic Disease. Clinics in Dermatology, 29, 511-522. https://doi.org/10.1016/j.clindermatol.2011.01.019
[35]
Shabestari, M., Vik, J., Reseland, J.E. and Eriksen, E.F. (2016) Bone Marrow Lesions in Hip Osteoarthritis Are Characterized by Increased Bone Turnover and Enhanced Angiogenesis. Osteoarthritis and Cartilage, 24, 1745-1752. https://doi.org/10.1016/j.joca.2016.05.009
[36]
Orr, J.D., Sabesan, V., Major, N. and Nunley, J. (2010) Painful Bone Marrow Edema Syndrome of the Foot and Ankle. Foot & Ankle International, 31, 949-953. https://doi.org/10.3113/fai.2010.0949
[37]
Paraskevopoulos, K., Keskinis, A., Vasios, I.S., Makiev, K.G., Tilkeridis, K., Drosos, G.I., et al. (2022) Comparison of Various Treatment Modalities for the Management of Bone Marrow Edema Syndrome/Transient Osteoporosis in Men and Non-Pregnant Women: A Systematic Review. Osteoporosis International, 34, 269-290. https://doi.org/10.1007/s00198-022-06584-8
[38]
Zhang, L., Cui, Y., Liang, D., Guan, J., Liu, Y. and Chen, X. (2020) High-Energy Focused Extracorporeal Shock Wave Therapy for Bone Marrow Edema Syndrome of the Hip. Medicine, 99, e19747. https://doi.org/10.1097/md.0000000000019747
[39]
Nencini, S. and Ivanusic, J. (2017) Mechanically Sensitive Aδ Nociceptors That Innervate Bone Marrow Respond to Changes in Intra-Osseous Pressure. The Journal of Physiology, 595, 4399-4415. https://doi.org/10.1113/jp273877
[40]
Yi, S.R., Lee, Y.H. and Kim, H.M. (2015) Bilateral Bone Marrow Edema Syndrome of the Femoral Head with a Unique Onset: A Case Report. Hip & Pelvis, 27, 273-277. https://doi.org/10.5371/hp.2015.27.4.273
[41]
Galluccio, F., Allam, A.E.S., Perdisa, F. and Chang, K. (2020) Short-Term Teriparatide for Bone Marrow Edema Secondary to Complex Regional Pain Syndrome: Case Reports on Efficacy after Two Years of Follow-Up. Cureus, 12, e8119. https://doi.org/10.7759/cureus.8119
[42]
Altan, M., Bayram, S., Salduz, A., Özmen, E. and Ekinci, M. (2019) An Unusual Cause of the Transient Osteoporosis of the Femoral Head: Essential Thrombocytosis. Journal of Orthopaedic Case Reports, 9, 41-44.
[43]
Cavalli, L., Falcone, G., Cavalli, T. and Pasquetti, P. (2020) Therapeutic and Functional Approach for the Treatment of Patients with Bone Marrow Edema in Rehabilitation Medicine. Beyond Rheumatology, 2, 43-50. https://doi.org/10.4081/br.2020.39
[44]
Radke, S., Kenn, W. and Eulert, J. (2004) Transient Bone Marrow Edema Syndrome Progressing to Avascular Necrosis of the Hip? A Case Report and Review of the Literature. Clinical Rheumatology, 23, 83-88. https://doi.org/10.1007/s10067-003-0820-4
[45]
Eriksen, E.F. (2015) Treatment of Bone Marrow Lesions (Bone Marrow Edema). BoneKey Reports, 4, Article 755. https://doi.org/10.1038/bonekey.2015.124
[46]
Baumbach, S.F., Pfahler, V., Bechtold-Dalla Pozza, S., Feist-Pagenstert, I., Fürmetz, J., Baur-Melnyk, A., et al. (2020) How We Manage Bone Marrow Edema—An Interdisciplinary Approach. Journal of Clinical Medicine, 9, Article 551. https://doi.org/10.3390/jcm9020551
[47]
Li, C., Zhao, Y., Zuo, Y., Zhou, Y., Zhang, F., Liu, S., et al. (2019) Efficacy of Bisphosphonates in Patients with Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome: A Prospective Open Study. Clinical and Experimental Rheumatology, 37, 663-669.
[48]
Tosun, H.B., Uludağ, A., Demir, S., Serbest, S., Yasar, M.M. and Öznam, K. (2020) Effectiveness of Iloprost in the Treatment of Bone Marrow Edema. Cureus, 12, e10547. https://doi.org/10.7759/cureus.10547
[49]
Beverly, M., Mellon, S., Kennedy, J.A. and Murray, D.W. (2018) Intraosseous Pressure during Loading and with Vascular Occlusion in an Animal Model. Bone & Joint Research, 7, 511-516. https://doi.org/10.1302/2046-3758.78.bjr-2017-0343.r2
[50]
Balfousias, T., Karadimas, E.J., Kakagia, D.D., Apostolopoulos, A. and Papanikolaou, A. (2020) Lower Limb Pain Attributed to Bone Marrow Edema Syndrome: A Commonly Ignored Pathology. Cureus, 12, e7469. https://doi.org/10.7759/cureus.7679
[51]
Ullah, A., Aly, A., Ali, T. and Alahmadi, I. (2021) Calcineurin Inhibitor-Induced Pain Syndrome: An Uncommon but a Debilitating Complication of Calcineurin Inhibitors Use. Saudi Journal of Kidney Diseases and Transplantation, 32, 1795-1799. https://doi.org/10.4103/1319-2442.352443
[52]
Eskandar, T., Chaudhary, F. and K Agrawal, D. (2024) Orthopedic Dermatopathies: Skin Manifestations in Orthopedic Conditions. Journal of Orthopaedics and Sports Medicine, 6, 171-183. https://doi.org/10.26502/josm.511500157
[53]
Molfetta L, Florian A, Saviola G, Frediani B. Bone Marrow Edema: pathogenetic features. Clin Ter. 2022 Sep-Oct;173(5):434-439. doi: 10.7417/CT.2022.2459. PMID: 36155729. https://pubmed.ncbi.nlm.nih.gov/36155729/
[54]
Pradhan, S., Bansal, R., Das, A., Pardasani, V., Malhotra, H.S., et al. (2022) Osteo-Cutaneous Trophic Changes in Complex Regional Pain Syndrome and their Reversal with Steroids. Neurology India, 70, 1119-1124. https://pubmed.ncbi.nlm.nih.gov/35864648/
[55]
Li, S., Yu, H., Long, S., Li, J., He, Y., Zheng, X., et al. (2023) Research Advances in the Treatment of Bone Marrow Edema Syndrome. Journal of Clinical Densitometry, 26, Article 101367. https://doi.org/10.1016/j.jocd.2023.03.006
[56]
Berger, C.E., Kröner, A.H., Minai-Pour, M.B., Ogris, E. and Engel, A. (2003) Biochemical Markers of Bone Metabolism in Bone Marrow Edema Syndrome of the Hip. Bone, 33, 346-351. https://doi.org/10.1016/s8756-3282(03)00164-9
